• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量阿糖胞苷化疗所致心包炎

Pericarditis induced by high-dose cytosine arabinoside chemotherapy.

作者信息

Hermans C, Straetmans N, Michaux J L, Ferrant A

机构信息

Hematology Department, Cliniques Universitaires Saint-Luc, Catholic University of Louvain, Brussels, Belgium.

出版信息

Ann Hematol. 1997 Jul-Aug;75(1-2):55-7. doi: 10.1007/s002770050312.

DOI:10.1007/s002770050312
PMID:9322684
Abstract

Pericarditis is a rare side effect of chemotherapy. We report here the case of a patient treated with high-dose cytosine arabinoside (HD ara-c) who developed severe pericarditis. Interruption of HD ara-c and initiation of corticosteroid treatment were effective in resolving the pericardial effusion. This case illustrates this rare but potentially life-threatening cardiac complication of HD ara-c therapy as well as the beneficial effect of corticosteroid treatment.

摘要

心包炎是化疗的一种罕见副作用。我们在此报告一例接受大剂量阿糖胞苷(HD ara-c)治疗的患者发生严重心包炎的病例。中断HD ara-c治疗并开始使用皮质类固醇治疗可有效消除心包积液。该病例说明了HD ara-c治疗这种罕见但可能危及生命的心脏并发症以及皮质类固醇治疗的有益效果。

相似文献

1
Pericarditis induced by high-dose cytosine arabinoside chemotherapy.大剂量阿糖胞苷化疗所致心包炎
Ann Hematol. 1997 Jul-Aug;75(1-2):55-7. doi: 10.1007/s002770050312.
2
High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.大剂量阿糖胞苷联合米托蒽醌治疗难治性急性髓系白血病和急性淋巴细胞白血病
Semin Oncol. 1987 Jun;14(2 Suppl 1):73-7.
3
High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia. Long-term follow-up of a prospective multicenter trial.高剂量阿糖胞苷和柔红霉素缓解后治疗成人初治急性髓系白血病。一项前瞻性多中心试验的长期随访
Ann Hematol. 1995 Nov;71(5):219-25. doi: 10.1007/BF01744371.
4
Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.阿糖胞苷联合米托蒽醌或柔红霉素用于既往未经治疗的成年急性非淋巴细胞白血病(ANLL)患者的随机多中心试验。莱德利协作组。
Leukemia. 1990 Mar;4(3):177-83.
5
[Cytarabine-induced pericarditis].[阿糖胞苷诱导的心包炎]
Rinsho Ketsueki. 1998 Nov;39(11):1115-20.
6
Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.高剂量阿糖胞苷和米托蒽醌治疗急性髓性白血病复发后出现暴发性肝衰竭。
Eur J Haematol. 1992 Oct;49(4):221-3. doi: 10.1111/j.1600-0609.1992.tb00052.x.
7
A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia.米托蒽醌联合阿糖胞苷与柔红霉素联合阿糖胞苷治疗初治成年急性非淋巴细胞白血病患者的随机研究。
Ann Hematol. 1994 Jul;69(1):11-5. doi: 10.1007/BF01757342.
8
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.阿柔比星联合阿糖胞苷与柔红霉素联合阿糖胞苷治疗初治急性髓系白血病患者的疗效比较:一项丹麦全国性III期试验。丹麦血液学会急性髓系白血病研究组,丹麦
Leukemia. 1991 Jun;5(6):510-6.
9
[Acute pericarditis caused by daunorubicin in acute myelocytic leukemia].[柔红霉素所致急性髓细胞白血病患者的急性心包炎]
Rinsho Ketsueki. 1988 Jun;29(6):874-8.
10
Acute pericarditis and pleural effusion complicating cytarabine chemotherapy.急性心包炎和胸腔积液并发阿糖胞苷化疗。
Onkologie. 2003 Aug;26(4):348-50. doi: 10.1159/000072094.

引用本文的文献

1
Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults: State-of-the-Art Review.成人造血干细胞移植后的心血管疾病:最新综述
JACC CardioOncol. 2024 Aug 20;6(4):475-495. doi: 10.1016/j.jaccao.2024.06.004. eCollection 2024 Aug.
2
Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology.代表意大利儿科血液肿瘤学协会感染病学工作组发布的《儿科肿瘤血液学患者新冠疫苗接种共识》
J Clin Med. 2022 Feb 24;11(5):1235. doi: 10.3390/jcm11051235.
3
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement.
5岁及以上正在接受癌症和非恶性血液疾病治疗的儿童及青少年的新冠病毒疫苗接种:澳大利亚和新西兰儿童血液学/肿瘤学组共识声明
Med J Aust. 2022 Apr 4;216(6):312-319. doi: 10.5694/mja2.51444. Epub 2022 Mar 10.
4
Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study.接受化疗的原发性中枢神经系统淋巴瘤患者的心血管死亡风险:一项基于登记处的队列研究。
Front Oncol. 2021 May 11;11:641955. doi: 10.3389/fonc.2021.641955. eCollection 2021.
5
Pericardectomy after pericarditis constrictiva led to onset of transplant kidney function after 98 days of anuric kidney graft: a case report.缩窄性心包炎心包切除术后,无尿肾移植 98 天后移植肾功能恢复:病例报告。
BMC Nephrol. 2020 Jun 29;21(1):241. doi: 10.1186/s12882-020-01899-2.
6
Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.癌症治疗相关的心包疾病:流行病学、临床表现、诊断和管理。
Curr Cardiol Rep. 2019 Nov 25;21(12):156. doi: 10.1007/s11886-019-1225-6.
7
Prevention of High-Dose Cytosine Arabinoside-Induced Acute Pericarditis with Preemptive Dexamethasone Administration: A Case Report and Literature Review.预防性使用地塞米松预防大剂量阿糖胞苷诱导的急性心包炎:一例报告及文献综述
Case Rep Hematol. 2018 Feb 11;2018:4726451. doi: 10.1155/2018/4726451. eCollection 2018.
8
Comprehensive review of cardiovascular toxicity of drugs and related agents.药物和相关制剂的心血管毒性的综合评价
Med Res Rev. 2018 Jul;38(4):1332-1403. doi: 10.1002/med.21476. Epub 2018 Jan 5.
9
Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report.阿糖胞苷治疗急性髓细胞白血病相关的心包炎:一例报告
Eur J Clin Pharmacol. 2018 Feb;74(2):181-182. doi: 10.1007/s00228-017-2355-7. Epub 2017 Oct 27.
10
Post-transfusion breathlessness in a patient with acute myeloid leukaemia.一名急性髓系白血病患者输血后出现呼吸急促
BMJ Case Rep. 2015 Jun 23;2015:bcr2015210131. doi: 10.1136/bcr-2015-210131.